Summary

Europe Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2026

Summary

Pharmaceuticals in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The European pharmaceuticals market had total revenues of $337.9 billion in 2021, representing a compound annual growth rate (CAGR) of 4.7% between 2016 and 2021.
- An aging population in many countries in Europe has helped to drive demand for pharmaceutical products due to greater treatment requirements for age-associated diseases such as diabetes and cardiovascular diseases.
- Germany, France, and the UK are the leading European pharmaceutical markets, with a 23.6%, 21.5%, and 9.0% share of the market, respectively, in 2021.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Europe
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Europe
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Europe pharmaceuticals market with five year forecasts

Reasons to Buy

- What was the size of the Europe pharmaceuticals market by value in 2021?
- What will be the size of the Europe pharmaceuticals market in 2026?
- What factors are affecting the strength of competition in the Europe pharmaceuticals market?
- How has the market performed over the last five years?
-

ページTOPに戻る

Table of Contents

Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths and weaknesses of leading players?
7.4. How have leading players responded to the COVID-19 pandemic?
7.5. Are there any threats toward leading players?
8 Company Profiles
8.1. F. Hoffmann-La Roche Ltd
8.2. Novartis AG
8.3. Johnson & Johnson
8.4. Pfizer Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine